Antibiyotiğe Bağlı İshal Patogenezi ve Neden Olan Mikroorganizmalar
Özet
Referanslar
Barlett JG. Antibiotic-associated diarrhea, N Engl J Med 2002;346:334-339.
Johnston BC, Goldenberg JZ, Vandvik PO, Sun X, and Guyatt GH. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev 2011: CD004827.
Akova M,Antibiyotikle İlişkili İshalde Epidemiyoloji Ve Risk Faktörleri, ANKEM Derg 2004; 18 (Ek 2): 80-81.
Wistrom J, Norrby SR, Myhre EB et al: Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study, J Antimicrob Chemother 2001;47:43.
Antunes LC, Han J, Ferreira RB, Lolic P, Borchers CH, and Finlay BB. Effect of antibiotic treatment on the intestinal metabolome. Antimicrob Agents Chemother 2011; 55:1494- 503. https://doi.org/10.1128/AAC.01664-10
Madsen KL. The use of probiotics in gastrointestinal disease. Can J Gastroenterol 2001; 15:817-822. https://doi.org/10.1155/2001/690741
McFarland LV. Antibiotic-associated diarrhea: epidemiology, trends and treatment. Future Microbiol 2008; 3:563-578. https://doi.org/10.2217/17460913.3.5.563
Lawley TD, and Walker AW. Intestinal colonization resistance. Immunology 2013; 138:1-11. https://doi.org/10.1111/j.1365-2567.2012.03616.x
Gantois I, Ducatelle R, Pasmans F, Haesebrouck F, Hautefort I, Thompson A, et al. Butyrate specifically down-regulates salmonella pathogenicity island 1 gene expression. Appl Environ Microbiol 2006; 72:946-949.
Bartlett JG. Management of Clostridium difficile infection and other antibiotic-associated diarrhoeas. Eur J Gastroenterol Hepatol 1996; 8:1054
Riegler M, Sedivy R, Pothoulakis C, et al. Clostridium Difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro. J Clin Invest 1995; 95:2004–11.
Yamamoto-Osaki T, Kamiya S, Sawamura S, Kai M, Ozawa A. Growth inhibition of Clostridium Difficile by intestinal flora of infant faeces in continuous flow culture. J Med Microbiol 1994; 40:179–87.
Larson HE, Borriello SP. Infectious diarrhea due to Clostridium perfringens. J Infect Dis 1988; 157:390–1.
Taylor M, Ajayi F, Almond M. Enterocolitis caused by methicillin-resistant staphylococcus Aureus. Lancet 1993; 342:804
Holmberg SD, Osterholm MT, Senger KA, Cohen ML. Drug-resistant Salmonella from animal fed antimicrobials. N Engl J Med 1984;311: 617–22.
Levine J, Dykoski RK, Janoff EN. Candida-associated diarrhea: a syndrome in search of credibility. Clin Infect Dis 1995; 21:881–6.
Pothoulakis C. Pathogenesis of Clostridium difficile–associated diarrhoea. Eur J Gastroenterol Hepatol 1996; 8:1041–7
Borriello SP, Larson HE, Welch AR, Barclay F. Enterotoxigenic Clostridium perfringens: a possible cause of antibiotic-associated diarrhoea. Lancet 1984; 1:305–7
Referanslar
Barlett JG. Antibiotic-associated diarrhea, N Engl J Med 2002;346:334-339.
Johnston BC, Goldenberg JZ, Vandvik PO, Sun X, and Guyatt GH. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev 2011: CD004827.
Akova M,Antibiyotikle İlişkili İshalde Epidemiyoloji Ve Risk Faktörleri, ANKEM Derg 2004; 18 (Ek 2): 80-81.
Wistrom J, Norrby SR, Myhre EB et al: Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study, J Antimicrob Chemother 2001;47:43.
Antunes LC, Han J, Ferreira RB, Lolic P, Borchers CH, and Finlay BB. Effect of antibiotic treatment on the intestinal metabolome. Antimicrob Agents Chemother 2011; 55:1494- 503. https://doi.org/10.1128/AAC.01664-10
Madsen KL. The use of probiotics in gastrointestinal disease. Can J Gastroenterol 2001; 15:817-822. https://doi.org/10.1155/2001/690741
McFarland LV. Antibiotic-associated diarrhea: epidemiology, trends and treatment. Future Microbiol 2008; 3:563-578. https://doi.org/10.2217/17460913.3.5.563
Lawley TD, and Walker AW. Intestinal colonization resistance. Immunology 2013; 138:1-11. https://doi.org/10.1111/j.1365-2567.2012.03616.x
Gantois I, Ducatelle R, Pasmans F, Haesebrouck F, Hautefort I, Thompson A, et al. Butyrate specifically down-regulates salmonella pathogenicity island 1 gene expression. Appl Environ Microbiol 2006; 72:946-949.
Bartlett JG. Management of Clostridium difficile infection and other antibiotic-associated diarrhoeas. Eur J Gastroenterol Hepatol 1996; 8:1054
Riegler M, Sedivy R, Pothoulakis C, et al. Clostridium Difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro. J Clin Invest 1995; 95:2004–11.
Yamamoto-Osaki T, Kamiya S, Sawamura S, Kai M, Ozawa A. Growth inhibition of Clostridium Difficile by intestinal flora of infant faeces in continuous flow culture. J Med Microbiol 1994; 40:179–87.
Larson HE, Borriello SP. Infectious diarrhea due to Clostridium perfringens. J Infect Dis 1988; 157:390–1.
Taylor M, Ajayi F, Almond M. Enterocolitis caused by methicillin-resistant staphylococcus Aureus. Lancet 1993; 342:804
Holmberg SD, Osterholm MT, Senger KA, Cohen ML. Drug-resistant Salmonella from animal fed antimicrobials. N Engl J Med 1984;311: 617–22.
Levine J, Dykoski RK, Janoff EN. Candida-associated diarrhea: a syndrome in search of credibility. Clin Infect Dis 1995; 21:881–6.
Pothoulakis C. Pathogenesis of Clostridium difficile–associated diarrhoea. Eur J Gastroenterol Hepatol 1996; 8:1041–7
Borriello SP, Larson HE, Welch AR, Barclay F. Enterotoxigenic Clostridium perfringens: a possible cause of antibiotic-associated diarrhoea. Lancet 1984; 1:305–7
